SCHEMBL707514

SCHEMBL707514

O=C(Nc1ccn(Cc2ccc(O)cc2C(F)(F)F)n1)c1ccccc1

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
STIM1 Q13586 2/20 0.74
ORAI1 Q96D31 2/20 0.74
ORAI3 Q9BRQ5 1/20 0.74
SMN1; SMN2 Q16637 10/20 0.56
LMNA P02545 7/20 0.56
NPC1 O15118 5/20 0.56
RAB9A P51151 5/20 0.56
ALDH1A1 P00352 4/20 0.54
NFKB1 P19838 1/20 0.53
NFKB2 Q00653 1/20 0.53
RELA Q04206 1/20 0.53
PTGER1 P34995 1/20 0.53
PKM P14618 1/20 0.47
NPSR1 Q6W5P4 3/20 0.47
HTT P42858 2/20 0.47
STAT3 P40763 2/20 0.46
MAPT P10636 2/20 0.46
HPGD P15428 1/20 0.46
TSHR P16473 1/20 0.45
P2RY14 Q15391 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL695450 0.88 STIM1 (0.59) STIM1ORAI1ORAI3SMN1; SMN2LMNA
SCHEMBL705705 0.85 STIM1 (1.00) STIM1ORAI1ORAI3SMN1; SMN2LMNA
SCHEMBL29420774 0.85 STIM1 (1.00) STIM1ORAI1ORAI3SMN1; SMN2LMNA
SCHEMBL700946 0.85 STIM1 (0.55) STIM1ORAI1ORAI3SMN1; SMN2LMNA
SCHEMBL757594 0.85 STIM1 (0.98) STIM1ORAI1ORAI3SMN1; SMN2LMNA
SCHEMBL757593 0.85 STIM1 (0.98) STIM1ORAI1ORAI3SMN1; SMN2LMNA
SCHEMBL759966 0.81 STIM1 (0.71) STIM1ORAI1ORAI3SMN1; SMN2LMNA
SCHEMBL758607 0.80 STIM1 (0.65) STIM1ORAI1ORAI3SMN1; SMN2LMNA
SCHEMBL756398 0.80 STIM1 (0.65) STIM1ORAI1ORAI3SMN1; SMN2LMNA
SCHEMBL696026 0.78 STIM1 (0.79) STIM1ORAI1ORAI3SMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2421835-A1 N-PYRAZOLYL CARBOXAMIDES AS CRAC CHANNEL INHIBITORS Glaxo Group Limited (GB) 2012-02-29 EP disclosed